ReviewArchives of microbiology2026
Terpene-based biofuels production: a revolutionizing role of cyanobacteria through metabolic engineering, opportunities and challenges.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing interest in biofuels has highlighted the potential of cyanobacteria due to their photoautotrophic mode of energy production, lower nutrient requirements for growth, and amenability to genetic modification using various genome engineering tools for the production of different types of biofuels. Terpene-based biofuels remain largely underexploited commercially and are currently limited to pilot-scale production. However, with extensive ongoing research, it may become possible to replace traditional fuels with terpenes as fuel additives for modern engines and aircraft. This review critically discusses various cyanobacterial species and strains used for the production of different terpenes, which are in high demand at present. Recent technologies, including high-density cultivation and multi-cultivator systems, significantly enhance terpene production in genetically engineered cyanobacteria, when applied to genetically improved strains. The commonly utilized cyanobacterial strains in recent studies include Synechococcus elongatus PCC 7942 and PCC 7002, Synechocystis PCC 6803 as well as fast-growing strains such as Synechococcus UTEX 2973, all of which possess strong genetic backgrounds suitable for industrial applications. Moreover, this review emphasizes emerging opportunities such as the efficient conversion of CO₂ into terpenes through the overexpression of endogenous MEP pathway genes or the introduction of exogenous MVA pathway genes. It also highlights advancements in CRISPR technology, integrated with genome-scale metabolic modelling. Finally, it addresses key challenges that must be considered for sustainable terpene biosynthesis, including terpene synthase enzyme expression, rate-limiting steps in upstream and downstream pathways, competition with native metabolic pathways, and target product toxicity, all of which may impair cyanobacterial growth. To overcome these challenges, continued metabolic engineering strategies are essential for achieving sustainable terpene-based biofuel production and facilitating the transition toward a green bioeconomy.
Indexed as
Identifiers
42554869What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.